Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032
Overview
The Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market is expected to reach a 878.93 USD Million by 2032 and is projected to grow at a CAGR of 80.07% from 2025 to 2032.
Revenue, 2024 (USD Million)
33.64
Forecast, 2032 (USD Million)
878.93
CAGR, 2024 - 2032
80.07%
Report Coverage
Australia & New Zealand
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market 2018-2032 USD Million
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 33.64 USD Million
- Projected Market Size (2032): 878.93 USD Million
- CAGR (2025-2032): 80.07%
Key Findings of Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market
- The Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market was valued at 33.64 USD Million in 2024.
- The Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market is likely to grow at a CAGR of 80.07% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Small Molecule in Drug Type Segment accounted for the largest share of the market with a revenue of 27.70 USD Million
- The fastest growing segment Novel Drug Candidates in Application Segment grew Fastest with a CAGR of 92.74% during the forecast period from 2024 to 2032.
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market Scope
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market Segmentation & Scope
End Use
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
Indication
- Others
- Metabolic Diseases
- Cardiovascular Diseases
- Neurodegenerative Diseases
- Immuno-Oncology
Application
- Others
- Finding New Disease-Associated Targets and Pathways
- Understanding Disease Mechanisms
- Formation & Qualification of Hypotheses
- Finding Drug Targets of an Old Drug
- De Novo Drug Design
- Aggregating and Synthesizing Information
- Drug Monitoring
- Drug Optimisation and Re-purposing Pre-clinical testing and approval
- Novel Drug Candidates
Drug Type
- Large Molecule
- Small Molecule
Technology
- Others
- Natural Language Processing (NLP)
- Deep Learning
- Machine Learning (ML)
Offering
- Services
- Software
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 33.64 USD Million |
| Market Value in 2032 | 878.93 USD Million |
| CAGR (2025-2032) | 80.07% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End Use,Indication,Application,Drug Type,Technology,Offering |
Regional Insights:
-
Leading Market (2024-2032): Australia & New Zealand, leading in terms of revenue 33.64 USD Million in 2024
- Key Country: Australia & New Zealand, leading in terms of revenue with value of 33.64 USD Million in 2024.
Segments and Scope
-
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032, By End Use
- Contract Research Organizations is the largest segment in Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 16.45 USD Million in the year 2024.
- Contract Research Organizations is the Fastest growing segment in Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 84.49 % in forecast period 2025-2032.
-
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Indication
- Immuno-Oncology is the largest segment in Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 14.41 USD Million in the year 2024.
- Immuno-Oncology is the Fastest growing segment in Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 82.92 % in forecast period 2025-2032.
-
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Application
- Novel Drug Candidates is the largest segment in Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 11.06 USD Million in the year 2024.
- Novel Drug Candidates is the Fastest growing segment in Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 92.74 % in forecast period 2025-2032.
-
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Drug Type
- Small Molecule is the largest segment in Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 27.70 USD Million in the year 2024.
- Small Molecule is the Fastest growing segment in Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 80.68 % in forecast period 2025-2032.
-
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Technology
- Machine Learning (ML) is the largest segment in Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 17.63 USD Million in the year 2024.
- Machine Learning (ML) is the Fastest growing segment in Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 82.24 % in forecast period 2025-2032.
-
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Offering
- Software is the largest segment in Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 19.80 USD Million in the year 2024.
- Services is the Fastest growing segment in Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 76.03 % in forecast period 2025-2032.
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market Company Share Analysis
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market Geographical Sales Distribution, 2018-2032 USD Million
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market is segmented based on Segmentation End Use,Indication,Application,Drug Type,Technology,Offering.
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 33.64(Revenue in USD Million) in 2020.
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market is projected to grow at a CAGR of 80.07% during the forecast period of 2024 to 2032.
The Small Molecule segment is expected to dominate the Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market, holding a largest market share of 27.70 USD Million in 2024
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market Scope
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market Segmentation & Scope
End Use
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
Indication
- Others
- Metabolic Diseases
- Cardiovascular Diseases
- Neurodegenerative Diseases
- Immuno-Oncology
Application
- Others
- Finding New Disease-Associated Targets and Pathways
- Understanding Disease Mechanisms
- Formation & Qualification of Hypotheses
- Finding Drug Targets of an Old Drug
- De Novo Drug Design
- Aggregating and Synthesizing Information
- Drug Monitoring
- Drug Optimisation and Re-purposing Pre-clinical testing and approval
- Novel Drug Candidates
Drug Type
- Large Molecule
- Small Molecule
Technology
- Others
- Natural Language Processing (NLP)
- Deep Learning
- Machine Learning (ML)
Offering
- Services
- Software
Frequently Asked Questions
The Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market is segmented based on Segmentation End Use,Indication,Application,Drug Type,Technology,Offering.
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 33.64(Revenue in USD Million) in 2020.
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market is projected to grow at a CAGR of 80.07% during the forecast period of 2024 to 2032.
The estimated market value of the Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market for final year is USD 878.93 (USD Million).
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market Company Profiling
Frequently Asked Questions
The Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market is segmented based on Segmentation End Use,Indication,Application,Drug Type,Technology,Offering.
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 33.64(Revenue in USD Million) in 2020.
Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market is projected to grow at a CAGR of 80.07% during the forecast period of 2024 to 2032.
The estimated market value of the Australia & New Zealand Artificial Intelligence (AI) in Drug Discovery Market for final year is USD 878.93 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.